发明名称 HETEROCYCLIC COMPOUNDS AS NAV CHANNEL INHIBITORS AND USES THEREOF
摘要 The present invention relates to heterocyclic compounds, and pharmaceutically acceptable compositions thereof, useful as Nav1.6 inhibitors.
申请公布号 US2015266862(A1) 申请公布日期 2015.09.24
申请号 US201514632287 申请日期 2015.02.26
申请人 Merck Patent GmbH 发明人 SHERER Brian A.;BRUGGER Nadia
分类号 C07D405/14;C07D207/16;C07D403/06;C07D401/12;C07D401/14 主分类号 C07D405/14
代理机构 代理人
主权项 1. A compound of formula I,or a pharmaceutically acceptable salt thereof, wherein: Z1 is C(R)(R), C(O), C(S), or C(NR); Z2 is C(R)(R), O, S, SO, SO2, or NR; X is —O—, —S—, —SO2—, —SO—, —C(O)—, —CO2—, —C(O)N(R)—, —NRC(O)—, —NRC(O)N(R)—, —NRSO2—, or —N(R)—; or X is absent; A is a C1-6 aliphatic, C5-10 aryl, a 3-8 membered saturated or partially unsaturated carbocyclic ring, a 3-7 membered heterocylic ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or a 5-6 membered heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur; each of which is optionally substituted; R1 is —R, halogen, -haloalkyl, —OR, —SR, —CN, —NO2, —SO2R, —SOR, —C(O)R, —CO2R, —C(O)N(R)2, —NRC(O)R, —NRC(O)N(R)2, —NRSO2R, or —N(R)2; each of R2, R3, R4, and R5, is independently H or C1-6 aliphatic; Y is —CH2—, —O—, —S—, —SO2—, —SO—, —C(O)—, —CO2—, —C(O)N(R)—, —NRC(O)—, —NRC(O)N(R)—, —NRSO2—, or —N(R)—; Ring B is C5-10 aryl or a 5-6 membered heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur; each of which is optionally substituted; each R6 is independently —R, halogen, -haloalkyl, —OR, —SR, —CN, —NO2, —SO2R, —SOR, —C(O)R, —CO2R, —C(O)N(R)2, —NRC(O)R, —NRC(O)N(R)2, —NRSO2R, or —N(R)2; m is 0, 1, 2, or 3; n is 0, 1, 2, or 3; q is 0, 1, 2, or 3; r is 1 or 2; and each R is independently hydrogen, C1-6 aliphatic, C5-10 aryl, a 3-8 membered saturated or partially unsaturated carbocyclic ring, a 3-7 membered heterocylic ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or a 5-6 membered monocyclic heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur; each of which is optionally substituted; or two R groups on the same atom are taken together with the atom to which they are attached to form a C3-10 aryl, a 3-8 membered saturated or partially unsaturated carbocyclic ring, a 3-7 membered heterocylic ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or a 5-6 membered monocyclic heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur; each of which is optionally substituted.
地址 Darmstadt DE
您可能感兴趣的专利